$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

$nvos Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224028543 Filed on July 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue		$3.152M	$3.293M
YoY Change		-4.28%	-76.23%
Cost Of Revenue		$2.255M	$1.979M
YoY Change		13.95%	-82.71%
Gross Profit		$896.9K	$1.314M
YoY Change		-31.75%	-45.45%
Gross Profit Margin		28.46%	39.91%
Selling, General & Admin		$3.417M	$2.745M
YoY Change		24.51%	-24.01%
% of Gross Profit		380.99%	208.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$556.7K	$579.6K
YoY Change		-3.95%	-34.26%
% of Gross Profit		62.07%	44.11%
Operating Expenses		$3.417M	$2.745M
YoY Change		24.51%	-24.01%
Operating Profit		-$2.520M	-$1.430M
YoY Change		76.19%	18.93%
Interest Expense		$178.4K	-$54.88K
YoY Change		-425.15%	-110.69%
% of Operating Profit
Other Income/Expense, Net		-$11.22M	-$54.88K
YoY Change		20338.61%	-97.84%
Pretax Income		-$13.74M	-$1.485M
YoY Change		824.82%	-60.33%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$13.74M	-$1.497M
YoY Change		817.76%	-60.7%
Net Earnings / Revenue		-435.99%	-45.47%
Basic Earnings Per Share		-$0.74	-$0.01
Diluted Earnings Per Share		-$0.74	-$0.01
COMMON SHARES
Basic Shares Outstanding	19.05M shares	19.05M shares	144.9M shares
Diluted Shares Outstanding		18.69M shares	14.36M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.540M	$464.0K
YoY Change		231.84%	-96.34%
Cash & Equivalents	$844.6K	$1.540M	$464.0K
Short-Term Investments
Other Short-Term Assets		$214.4K	$221.4K
YoY Change		-3.15%	-41.86%
Inventory	$1.001M	$1.112M	$938.9K
Prepaid Expenses
Receivables	$1.917M	$2.252M	$1.328M
Other Receivables	$1.235M	$1.043M	$1.046M
Total Short-Term Assets	$5.415M	$6.161M	$3.998M
YoY Change	23.4%	54.11%	-80.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.111M	$5.158M	$7.508M
YoY Change	-5.18%	-31.3%	26.57%
Goodwill	$6.554M	$7.524M	$7.543M
YoY Change	-13.56%	-0.25%	-33.64%
Intangibles	$13.37M	$14.69M	$16.70M
YoY Change	-17.56%	-12.02%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$26.73M	$29.17M	$31.75M
YoY Change	-14.27%	-8.13%	-38.61%
TOTAL ASSETS
Total Short-Term Assets	$5.415M	$6.161M	$3.998M
Total Long-Term Assets	$26.73M	$29.17M	$31.75M
Total Assets	$32.14M	$35.33M	$35.75M
YoY Change	-9.62%	-1.17%	-50.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.236M	$3.895M	$1.896M
YoY Change	-7.91%	105.41%	16.92%
Accrued Expenses	$1.592M	$1.332M	$1.922M
YoY Change	29.08%	-30.69%	54.56%
Deferred Revenue	$239.4K		$35.64K
YoY Change	575.53%
Short-Term Debt		$1.487M	$1.058M
YoY Change		40.52%	-54.62%
Long-Term Debt Due		$1.008M	$1.239M
YoY Change		-18.65%	-76.53%
Total Short-Term Liabilities	$14.58M	$22.68M	$6.209M
YoY Change	84.44%	265.24%	-51.23%
LONG-TERM LIABILITIES
Long-Term Debt		$63.57K	$64.95K
YoY Change		-2.12%	-99.43%
Other Long-Term Liabilities		$1.534M	$1.787M
YoY Change		-14.15%	3.01%
Total Long-Term Liabilities		$1.598M	$1.852M
YoY Change		-13.73%	-85.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.58M	$22.68M	$6.209M
Total Long-Term Liabilities		$1.598M	$1.852M
Total Liabilities	$17.53M	$25.66M	$9.178M
YoY Change	58.42%	179.61%	-66.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$83.20M	-$88.20M	-$63.87M
YoY Change	24.12%	38.09%	103.47%
Common Stock	$19.06K	$19.06K	$144.9K
YoY Change	20.91%	-86.85%	372.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.89M	$9.956M	$26.57M
YoY Change
Total Liabilities & Shareholders Equity	$32.14M	$35.33M	$35.75M
YoY Change	-9.62%	-1.17%	-50.21%

Cashflow Statement

Concept	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$13.74M	-$1.497M
YoY Change	817.76%	-60.7%
Depreciation, Depletion And Amortization	$556.7K	$579.6K
YoY Change	-3.95%	-34.26%
Cash From Operating Activities	-$658.0K	-$857.7K
YoY Change	-23.29%	-75.84%
INVESTING ACTIVITIES
Capital Expenditures	$2.010K	$18.87K
YoY Change	-89.35%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$2.010K	-$18.87K
YoY Change	-89.35%	-105.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.820M	901.0K
YoY Change	101.95%	-2519.52%
NET CHANGE
Cash From Operating Activities	-658.0K	-857.7K
Cash From Investing Activities	-2.010K	-18.87K
Cash From Financing Activities	1.820M	901.0K
Net Change In Cash	1.160M	24.44K
YoY Change	4644.76%	-100.75%
FREE CASH FLOW
Cash From Operating Activities	-$658.0K	-$857.7K
Capital Expenditures	$2.010K	$18.87K
Free Cash Flow	-$660.0K	-$876.6K
YoY Change	-24.71%	-75.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17688692	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
CY2023Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1400499	usd
CY2023Q3	us-gaap	Liabilities Liabilities	11063972	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19054523	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15759325	shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90973316	usd
CY2024Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	1700	shares
CY2023Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	91138	shares
CY2024Q2	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	25500	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1452386	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-357383	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88201415	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67033041	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9956134	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	24815945	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-292913	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-316870	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9663221	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35327000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35563047	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3151851	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3292933	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10213661	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9268722	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	2254958	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1978839	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6048664	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5244192	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	896893	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1314094	usd
	us-gaap	Gross Profit GrossProfit	4164997	usd
	us-gaap	Gross Profit GrossProfit	4024530	usd
CY2024Q2	us-gaap	Selling Expense SellingExpense	2635	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	1877	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11527794	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9473802	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2744512	usd
	us-gaap	Operating Expenses OperatingExpenses	11542605	usd
	us-gaap	Operating Expenses OperatingExpenses	9483718	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2520203	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001138978
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	NVOS	Stock Issued During Period Value To Be Issued StockIssuedDuringPeriodValueToBeIssued		usd
CY2023Q4	NVOS	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits		usd
CY2022Q4	NVOS	Stock Issued During Period Value To Be Issued StockIssuedDuringPeriodValueToBeIssued		usd
CY2023Q1	NVOS	Stock Issued During Period Value To Be Issued StockIssuedDuringPeriodValueToBeIssued		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NVOS	Beneficial Conversion Feature Upon Issuance Of Convertible Notes BeneficialConversionFeatureUponIssuanceOfConvertibleNotes		usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability		usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote		usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions		usd
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes		usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes		usd
	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2024Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2023Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	NVOS	Unamortized Stock Option Expense UnamortizedStockOptionExpense		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2024Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue		usd
CY2024Q2	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableIntrinsicValue1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-05-31
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	NVOS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19054523	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1539771	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	416323	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2251528	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1112068	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1043473	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	214436	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	346171	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	6161276	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	4388089	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5157781	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14690038	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16218539	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1793907	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1983898	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7523998	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2024Q2	us-gaap	Assets Assets	35327000	usd
CY2023Q3	us-gaap	Assets Assets	35563047	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3894602	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3513842	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1332485	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	450795	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	382666	usd
CY2024Q2	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	93488	usd
CY2023Q3	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	277405	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	4985381	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1224619	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	558668	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	14048576	usd
CY2024Q2	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	45968	usd
CY2023Q3	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	61767	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4336	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	11744	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	409516	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	415392	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22676433	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7904858	usd
CY2024Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	63572	usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	65038	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1534078	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1693577	usd
CY2024Q2	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1389696	usd
CY2023Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1400499	usd
CY2024Q2	us-gaap	Liabilities Liabilities	25663779	usd
CY2023Q3	us-gaap	Liabilities Liabilities	11063972	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19054523	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19054523	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15759325	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	19055	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15760	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96660608	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90973316	usd
CY2024Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	1700	shares
CY2023Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	91138	shares
CY2024Q2	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	25500	usd
CY2023Q3	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	1217293	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1452386	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-357383	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88201415	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67033041	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9956134	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	24815945	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-292913	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-316870	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9663221	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35327000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35563047	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3151851	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3292933	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10213661	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9268722	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	2254958	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1978839	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6048664	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5244192	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	896893	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1314094	usd
	us-gaap	Gross Profit GrossProfit	4164997	usd
	us-gaap	Gross Profit GrossProfit	4024530	usd
CY2024Q2	us-gaap	Selling Expense SellingExpense	2635	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	1877	usd
	us-gaap	Selling Expense SellingExpense	9916	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2742635	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11527794	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9473802	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	3417096	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2744512	usd
	us-gaap	Operating Expenses OperatingExpenses	11542605	usd
	us-gaap	Operating Expenses OperatingExpenses	9483718	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2520203	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1430418	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	62397	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6762	usd
CY2024Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	178445	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9570	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	460503	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	240520	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3431	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-964368	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6724690	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5765822	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2904830	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	156037	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5095331	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4386899	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1406915	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	48333	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1430418	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7377608	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5459188	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2214	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6910	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6762	usd
CY2024Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	178445	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9570	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	460503	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	240520	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3431	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-964368	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6724690	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5765822	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2904830	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	156037	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5095331	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4386899	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1406915	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	48333	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1485861	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11216097	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-54877	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13764975	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4608005	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13736300	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1485295	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21142583	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10067193	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	25791	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-13095	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-13741903	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1497330	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21168374	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10054098	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
	us-gaap	Profit Loss ProfitLoss	-21142583	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	750067	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1809769	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-738022	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12986233	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1605652	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19332814	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10805215	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18685979	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18685979	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8583229	shares
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1485861	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12652	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11216097	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-54877	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13764975	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4608005	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13736300	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1485295	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21142583	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10067193	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
	us-gaap	Profit Loss ProfitLoss	-21142583	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5603	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12035	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	25791	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-13095	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-13741903	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1497330	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10054098	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	750067	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-120357	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1809769	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-738022	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12986233	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1605652	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19332814	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10805215	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18685979	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18685979	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14360058	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14360058	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17688692	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8583229	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2023Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1323398	usd
CY2023Q4	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	240400	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2023Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1323398	usd
CY2023Q4	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	240400	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	577522	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1195400	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	108976	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23284048	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	750067	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	147656	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2745560	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21890284	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	579288	usd
CY2024Q2	NVOS	Cancellation Of Agreement CancellationOfAgreement	-18943	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	948892	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9663221	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1795000	usd
CY2022Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1139050	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-420982	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9086051	usd
CY2023Q1	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	282533	usd
CY2023Q1	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	131000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	82963	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	1390380	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-196683	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	100278	usd
CY2023Q2	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	320000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	90132	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	93811	usd
CY2023Q2	NVOS	Beneficial Conversion Feature Upon Issuance On Convertible Debt BeneficialConversionFeatureUponIssuanceOnConvertibleDebt	66068	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	263561	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-120357	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26291284	usd
	us-gaap	Profit Loss ProfitLoss	-21142583	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1697317	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1718388	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-147656	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-385335	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5765822	usd
	NVOS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	1323398	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	577522	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1195400	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	108976	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23284048	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	454073	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	750067	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	147656	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2745560	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21890284	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	579288	usd
CY2024Q2	NVOS	Cancellation Of Agreement CancellationOfAgreement	-18943	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	948892	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9663221	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1795000	usd
CY2022Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1139050	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-420982	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9086051	usd
CY2023Q1	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	282533	usd
CY2023Q1	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	131000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	82963	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	86327	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	1390380	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-196683	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	100278	usd
CY2023Q2	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	320000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	90132	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	93811	usd
CY2023Q2	NVOS	Beneficial Conversion Feature Upon Issuance On Convertible Debt BeneficialConversionFeatureUponIssuanceOnConvertibleDebt	66068	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	263561	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-120357	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26291284	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26291284	usd
	us-gaap	Profit Loss ProfitLoss	-21142583	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1697317	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1718388	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-147656	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-385335	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5765822	usd
	NVOS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	1323398	usd
	NVOS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	1421583	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1195400	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	466276	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	624246	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4386899	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12652	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	797692	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	308907	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12548	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	92260	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-130015	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-333724	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	154542	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	76428	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	104004	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	103605	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-67634	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-466276	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-594618	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4523923	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2014543	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2005	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2005	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-267756	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-56649	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	222000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	184125	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7350	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6435	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	8649153	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	925306	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3311536	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3033888	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1795000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	240400	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	451000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5119060	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296334	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	530316	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22403	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1123448	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1714676	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	416323	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2178687	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1539771	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	464011	usd
	us-gaap	Interest Paid Net InterestPaidNet	190491	usd
	us-gaap	Interest Paid Net InterestPaidNet	343878	usd
	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	1610883	usd
	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	9186329	usd
	NVOS	Beneficial Conversion Feature Upon Issuance Of Convertible Notes BeneficialConversionFeatureUponIssuanceOfConvertibleNotes	66068	usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	1390380	usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote	639993	usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions	1390380	usd
	NVOS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	1421583	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1195400	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	466276	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	624246	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5095331	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4386899	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1485861	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12652	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	797692	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	308907	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12548	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	92260	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-130015	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-333724	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	408067	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	154542	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	76428	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	104004	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	103605	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-67634	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-466276	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-594618	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4523923	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2014543	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2005	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18870	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2005	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18870	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-267756	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-56649	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	274	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	222000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	184125	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7350	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6435	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	8649153	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	925306	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3311536	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3033888	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	240400	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	451000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5119060	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296334	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	530316	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22403	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1123448	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1714676	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	416323	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2178687	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1539771	usd
	us-gaap	Interest Paid Net InterestPaidNet	190491	usd
	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	1610883	usd
	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	9186329	usd
	NVOS	Beneficial Conversion Feature Upon Issuance Of Convertible Notes BeneficialConversionFeatureUponIssuanceOfConvertibleNotes	66068	usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	1390380	usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote	639993	usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions	1390380	usd
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes	173095	usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	180138	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zxRS9RKlev5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to the going concern assessment, useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, valuation of share-based compensation and warrants, valuation of derivative liability, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes	173095	usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	180138	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zxRS9RKlev5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to the going concern assessment, useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, valuation of share-based compensation and warrants, valuation of derivative liability, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_89B_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_zPzciLNMI84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zZfKsY5jkYdh" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_z2OZnmun8PGc" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zpicccn9vyud" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zynVM5zjblPk" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zIe2x9aFNEue" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_89B_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_zPzciLNMI84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zZfKsY5jkYdh" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_z2OZnmun8PGc" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zpicccn9vyud" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zynVM5zjblPk" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zIe2x9aFNEue" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-243361	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-58485	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7523998	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-243361	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-58485	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7523998	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_849_eus-gaap--DerivativesReportingOfDerivativeActivity_zeMy0K9U7gml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Derivative Financial Instruments </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt under ASC 470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815. The Company applies the guidance in ASC 815-40-35-12 to determine the order in which each convertible instrument would be evaluated for derivative classification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to the fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zwMntt3FkcUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Reclassifications </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zwMntt3FkcUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Reclassifications </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	NVOS	Trade Receivables TradeReceivables	3040932	usd
CY2023Q3	NVOS	Trade Receivables TradeReceivables	2223243	usd
CY2024Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	49273	usd
CY2023Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	108000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3090205	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2331243	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	838677	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	864215	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2251528	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	439667	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	388391	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	197729	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	81696	usd
CY2024Q2	NVOS	Trade Receivables TradeReceivables	3040932	usd
CY2023Q3	NVOS	Trade Receivables TradeReceivables	2223243	usd
CY2024Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	49273	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3090205	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2331243	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	838677	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	864215	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2251528	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	439667	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	388391	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	197729	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	474672	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	1112068	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	1106983	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1112068	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2024Q2	us-gaap	Inventory Adjustments InventoryAdjustments	1444317	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	1043473	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	1051584	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1043473	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6594129	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6643247	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1436348	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1253209	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5157781	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
	us-gaap	Depreciation Depreciation	194458	usd
	us-gaap	Depreciation Depreciation	212579	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23759483	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23290546	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9069445	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7072007	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14690038	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1502859	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	474672	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	636896	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	1112068	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2024Q2	us-gaap	Inventory Adjustments InventoryAdjustments	1444317	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	1043473	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	1051584	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1043473	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6594129	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6643247	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1436348	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1253209	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5157781	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
	us-gaap	Depreciation Depreciation	194458	usd
	us-gaap	Depreciation Depreciation	212579	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23759483	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23290546	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9069445	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7072007	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14690038	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1502859	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1505809	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1505809	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2000212	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1583305	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1360814	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1060742	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	222046	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8462919	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14690038	usd
CY2024Q2	NVOS	Accrued Liabilities AccruedLiabilities	1047587	usd
CY2023Q3	NVOS	Accrued Liabilities AccruedLiabilities	961897	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	284898	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	236218	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35434	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1332485	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2024Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	157060	usd
CY2023Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	342443	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	93488	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	277405	usd
CY2024Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	63572	usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	65038	usd
	NVOS	Debt Instrument Default Repayment Percentage DebtInstrumentDefaultRepaymentPercentage	0.75	pure
CY2024Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2000212	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1360814	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1060742	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	222046	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8462919	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14690038	usd
CY2024Q2	NVOS	Accrued Liabilities AccruedLiabilities	1047587	usd
CY2023Q3	NVOS	Accrued Liabilities AccruedLiabilities	961897	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	284898	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	236218	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35434	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1332485	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2024Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	157060	usd
CY2023Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	342443	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	93488	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	277405	usd
CY2024Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	63572	usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	65038	usd
	NVOS	Debt Instrument Default Repayment Percentage DebtInstrumentDefaultRepaymentPercentage	0.75	pure
CY2024Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	93488	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	37212	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	157060	usd
CY2024Q2	us-gaap	Default Longterm Debt Description Of Violation Or Event Of Default DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault	The Company may prepay the Note at any time prior to the date that an Event of Default (as defined in the Streeterville Note) (each an “Event of Default”) occurs at an amount equal to 105% of the Outstanding Balance (as defined below). “Outstanding Balance” means the Streeterville Principal Sum then outstanding plus accrued and unpaid interest.
CY2024Q2	NVOS	Trigger Effect Description TriggerEffectDescription	The “Trigger Effect” means 20% of the Outstanding Balance upon the occurrence of any Major Trigger Event (as defined in the Streeterville Note) and 5% of the Outstanding Balance upon the occurrence of any Minor Trigger Event (as defined in the Streeterville Note). The Trigger Effect for any Minor Trigger Event may occur up to three times. Upon the occurrence of an Event of Default, additional interest will accrue from the date of the Event of Default at the rate equal to the lower of 22% per annum or the highest rate permitted by law.
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1793907	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1983898	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1793907	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1983898	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	409516	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	415392	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1943594	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2108969	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	93488	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6590	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	37212	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	157060	usd
CY2024Q2	us-gaap	Default Longterm Debt Description Of Violation Or Event Of Default DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault	The Company may prepay the Note at any time prior to the date that an Event of Default (as defined in the Streeterville Note) (each an “Event of Default”) occurs at an amount equal to 105% of the Outstanding Balance (as defined below). “Outstanding Balance” means the Streeterville Principal Sum then outstanding plus accrued and unpaid interest.
CY2024Q2	NVOS	Trigger Effect Description TriggerEffectDescription	The “Trigger Effect” means 20% of the Outstanding Balance upon the occurrence of any Major Trigger Event (as defined in the Streeterville Note) and 5% of the Outstanding Balance upon the occurrence of any Minor Trigger Event (as defined in the Streeterville Note). The Trigger Effect for any Minor Trigger Event may occur up to three times. Upon the occurrence of an Event of Default, additional interest will accrue from the date of the Event of Default at the rate equal to the lower of 22% per annum or the highest rate permitted by law.
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1793907	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1793907	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	415392	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1534078	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1693577	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1943594	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2108969	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	561953	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	540470	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	533653	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	335219	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	196310	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2379975	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	561953	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	540470	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	533653	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	335219	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	212370	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	196310	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2379975	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	436381	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1943594	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	409516	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1534078	usd
	us-gaap	Payments For Rent PaymentsForRent	466276	usd
	us-gaap	Payments For Rent PaymentsForRent	624246	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	440585	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	604387	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M6D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0869	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4401	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	4401	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	436381	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1943594	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	409516	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1534078	usd
	us-gaap	Payments For Rent PaymentsForRent	466276	usd
	us-gaap	Payments For Rent PaymentsForRent	624246	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	440585	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	604387	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M6D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0869	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4401	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	4401	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	65	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	4336	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4336	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19054523	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19054523	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15759325	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15759325	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	27973	shares
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	65	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	4336	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4336	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19054523	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19054523	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15759325	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15759325	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	27973	shares
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	371423	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.44
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M23D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.78
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548423	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M25D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	548423	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M25D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548423	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	548423	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	147656	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	385335	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	806254	shares
CY2023Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	12.05
CY2023	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M15D
CY2023Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue	106960	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	518061	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	288193	shares
CY2024Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	30.46
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M15D
CY2024Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableNumber	288193	shares
CY2024Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableWeightedAverageExercisePrice	30.46
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableWeightedAverageRemainingContractualTerm1	P2Y11M15D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	371423	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.44
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M23D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.78
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	23000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.74
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548423	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M25D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	548423	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M25D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548423	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	548423	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	147656	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	385335	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	806254	shares
CY2023	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M15D
CY2023Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue	106960	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	518061	shares
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M15D
CY2024Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableNumber	288193	shares
CY2024Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableWeightedAverageExercisePrice	30.46
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableWeightedAverageRemainingContractualTerm1	P2Y11M15D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	288193	shares
	us-gaap	Other Expenses OtherExpenses	652174	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3151851	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	288193	shares
	us-gaap	Other Expenses OtherExpenses	652174	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3151851	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3292933	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10213661	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9268722	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	896893	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1314094	usd
	us-gaap	Gross Profit GrossProfit	4164997	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2520203	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1430418	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7377608	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	579591	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1697317	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1718388	usd
CY2024Q2	NVOS	Capital Expenditures CapitalExpenditures	2005	usd
	NVOS	Capital Expenditures CapitalExpenditures	18870	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	178445	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	9570	usd
	us-gaap	Interest Expense InterestExpense	460503	usd
	us-gaap	Interest Expense InterestExpense	240520	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
	us-gaap	Profit Loss ProfitLoss	-21142583	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
CY2024Q2	us-gaap	Assets Assets	35327000	usd
CY2023Q3	us-gaap	Assets Assets	35563047	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2251528	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14690038	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3292933	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10213661	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9268722	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	896893	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1314094	usd
	us-gaap	Gross Profit GrossProfit	4164997	usd
	us-gaap	Gross Profit GrossProfit	4024530	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2520203	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1430418	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7377608	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5459188	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	556704	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	579591	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1697317	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1718388	usd
CY2024Q2	NVOS	Capital Expenditures CapitalExpenditures	2005	usd
CY2023Q2	NVOS	Capital Expenditures CapitalExpenditures	18870	usd
	NVOS	Capital Expenditures CapitalExpenditures	2005	usd
	NVOS	Capital Expenditures CapitalExpenditures	18870	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	178445	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	9570	usd
	us-gaap	Interest Expense InterestExpense	240520	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-13736300	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
	us-gaap	Profit Loss ProfitLoss	-21142583	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
CY2024Q2	us-gaap	Assets Assets	35327000	usd
CY2023Q3	us-gaap	Assets Assets	35563047	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2251528	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14690038	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7523998	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-028543-index-headers.html	Edgar Link	pending
0001493152-24-028543-index.html	Edgar Link	pending
0001493152-24-028543.txt	Edgar Link	pending
0001493152-24-028543-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvos-20240531.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
nvos-20240531_lab.xml	Edgar Link	unprocessable
nvos-20240531_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nvos-20240531_cal.xml	Edgar Link	unprocessable
nvos-20240531_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

2024 Q3 Form 10-Q Financial Statement

#000149315224028543 Filed on July 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS Novo Integrated Sciences, Inc. Stock $nvos

2024 Q3 Form 10-Q Financial Statement

#000149315224028543 Filed on July 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos